Relative to its peers, OGEN does not have very much institutional sponsorship. The 8.08% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KCG AMERICAS LLC Bought 125.9 Thousand shares of Oragenics Inc
CITADEL ADVISORS LLC Bought 19.8 Thousand shares of Oragenics Inc
BLACKROCK FUND ADVISORS Bought 1.0 Thousand shares of Oragenics Inc